Hancock Jaffe Laboratories 주식 가격. HJLI - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

10.38

매수가

10.00

매도가

10.70

거래량

0.00 일간 변동폭 0.00

0.00 52주 범위 0.00

market_cap

98.319M

전일 종가

10.38

개장가

최근 거래 시간

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

발행 주식

9,472,000

배당수익률

주가수익률

-4.18

주당순이익(EPS)

-2.48

매출

순이익

-23.52M

섹터

Surgical,med Instr,apparatus

산업

Surgical,med Instr,apparatus

웹사이트

www.envveno.com

본부

Wilmington, Delaware, USA

설립됨

Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

Hancock Jaffe Announces Objectives for Upcoming CoreoGraft Study

IRVINE, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference

IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

Hancock Jaffe Announces End Points for First-in-Human VenoValve Study

IRVINE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health...

Hancock Jaffe Receives Approval for First-in-Human VenoValve Study

IRVINE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

Hancock Jaffe Announces January CoreoGraft Study at the Texas Heart Institute

IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia

IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

Hancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance

IRVINE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

Hancock Jaffe Enters into Sponsored Research Agreement for CoreoGraft with World-Renowned Texas Heart Institute

IRVINE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health...

Hancock Jaffe Appoints Three New Independent Directors

Accomplished medical device professionals and nationally recognized fund manager and analystbring key experience to the leadership of cardiac and vascular device company IRVINE, Calif., Oct...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

HJLI - Frequently Asked Questions (FAQ)

What is the current Hancock Jaffe Laboratories share price?

The current share price of Hancock Jaffe Laboratories is US$ 10.38

How many Hancock Jaffe Laboratories shares are in issue?

Hancock Jaffe Laboratories has 9,472,000 shares in issue

What is the market cap of Hancock Jaffe Laboratories?

The market capitalisation of Hancock Jaffe Laboratories is USD 98.32M

What is the 1 year trading range for Hancock Jaffe Laboratories share price?

Hancock Jaffe Laboratories has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Hancock Jaffe Laboratories?

The price to earnings ratio of Hancock Jaffe Laboratories is -4.18

What is the reporting currency for Hancock Jaffe Laboratories?

Hancock Jaffe Laboratories reports financial results in USD

What is the latest annual profit for Hancock Jaffe Laboratories?

The latest annual profit of Hancock Jaffe Laboratories is USD -23.52M

What is the registered address of Hancock Jaffe Laboratories?

The registered address for Hancock Jaffe Laboratories is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the Hancock Jaffe Laboratories website address?

The website address for Hancock Jaffe Laboratories is www.envveno.com

Which industry sector does Hancock Jaffe Laboratories operate in?

Hancock Jaffe Laboratories operates in the SURGICAL,MED INSTR,APPARATUS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M